| RS1596369527 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596369682 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596374422 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS1596374943 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Isolated focal cortical dysplasia type II |
| RS1596375342 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596377439 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1596377481 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1596382055 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596382268 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596382441 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596382895 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596384304 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1596385588 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS1596385627 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596385749 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596386673 |
TPM1
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1596387135 |
VPS13C
|
Health Risk |
Likely pathogenic |
Young-onset Parkinson disease, Young-onset Parkinson disease |
| RS1596389437 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1596389562 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1596393434 |
DIAPH1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS1596400038 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596400436 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1596400563 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596404187 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596404280 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1596406306 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1596409872 |
IGF1R
|
Health Risk |
Likely pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1596413181 |
IGF1R
|
Health Risk |
Pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1596415173 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1596417662 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596418520 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596419511 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1596419766 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS1596421912 |
DIAPH1
|
Health Risk |
Likely pathogenic |
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS1596427937 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1596427956 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS1596427970 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1596429174 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1596432295 |
NR2F2
|
Health Risk |
Pathogenic |
— |
| RS1596436494 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1596439426 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596439555 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596441025 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1596442866 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1596443241 |
CHD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1596443444 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596447013 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS1596447015 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS1596455074 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596455392 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596456893 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1596457128 |
IGF1R
|
Health Risk |
Pathogenic |
— |
| RS1596457919 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596458294 |
CHD2
|
Health Risk |
Likely pathogenic |
— |
| RS1596459125 |
CHSY1
|
Health Risk |
Pathogenic |
Temtamy preaxial brachydactyly syndrome, Temtamy preaxial brachydactyly syndrome |
| RS1596460327 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Isolated focal cortical dysplasia type II |
| RS1596460606 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596468621 |
IGF1R
|
Health Risk |
Likely pathogenic |
— |
| RS1596468719 |
IGF1R
|
Health Risk |
Likely pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1596471547 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1596471581 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596471698 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1596471934 |
GRIN2A
|
Health Risk |
Pathogenic |
— |
| RS1596472276 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1596472500 |
ABAT
|
Health Risk |
Likely pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS1596472892 |
IGF1R
|
Health Risk |
Pathogenic/Likely pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1596473289 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS1596473420 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1596473434 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596474115 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596474136 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596474257 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596475245 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596475487 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1596476061 |
IGF1R
|
Health Risk |
Likely pathogenic |
NK-cell enteropathy, NK-cell enteropathy |
| RS1596476159 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Inborn genetic diseases |
| RS1596476163 |
IGF1R
|
Health Risk |
Likely pathogenic |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1596476300 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596476503 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1596476657 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Landau-Kleffner syndrome |
| RS1596480112 |
PKD1;PKD1-AS1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1596480400 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596481464 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1596481630 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1596481676 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1596481858 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596481889 |
PMM2
|
Health Risk |
Pathogenic/Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1596482597 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1596483044 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1596485727 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1596485816 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596485991 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1596488823 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1596488828 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1596489094 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1596489887 |
PMM2
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, Muscular dystrophy |
| RS1596490025 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1596494610 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1596494684 |
GRIN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1596500172 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |